Oncology Institute (TOI) Director Karen Marie Johnson Receives RSU Award

What Happened Karen Marie Johnson, a director of Oncology Institute, Inc. (TOI), received an award of 31,124 restricted stock units (RSUs) on 2026-07-27. The award was granted at $0.00 per share (no cash exchanged) and is reported as an "A" (award/grant) transaction. This is a compensation/share-award event rather than an open-market purchase or sale.

Key Details

• Transaction date: 2026-07-27; Form 4 filed 2026-07-29.
• Amount: 31,124 RSUs granted; per filing price reported as $0.00 (award).
• Shares owned after transaction: not disclosed in the provided filing.
• Footnote: F1 — each RSU entitles the holder to one share upon settlement; the RSUs vest in full on the date of the Issuer's 2027 annual meeting of stockholders, subject to continued service.
• Filing timeliness: Form 4 was filed two days after the report date (within the normal reporting window).

Context RSUs are a form of equity compensation that convert to common shares upon settlement and vesting; they do not represent an immediate market purchase or sale. Because vesting is contingent on continued service until the 2027 annual meeting, this award primarily reflects compensation structure rather than a direct insider view on the stock.